The estimated Net Worth of Cindy Reiss Clark is at least $2.36 Milión dollars as of 22 August 2023. Ms. Clark owns over 3,477 units of West Pharmaceutical Services stock worth over $2,357,423 and over the last 2 years she sold WST stock worth over $0. In addition, she makes $0 as Senior Vice President of Global Market Units and Commercial Solutions at West Pharmaceutical Services.
Sign up
Ms. Clark WST stock SEC Form 4 insiders trading
Cindy has made over 1 trades of the West Pharmaceutical Services stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 3,477 units of WST stock worth $915,007 on 22 August 2023.
The largest trade she's ever made was exercising 3,477 units of West Pharmaceutical Services stock on 22 August 2023 worth over $915,007. On average, Cindy trades about 1,159 units every 0 days since 2023. As of 22 August 2023 she still owns at least 7,797 units of West Pharmaceutical Services stock.
You can see the complete history of Ms. Clark stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Cindy Reiss-Clark biography
Cindy Reiss-Clark serves as Senior Vice President of Global Market Units and Commercial Solutions of the Company. Ms. Cindy serves as Senior Vice President, Global Market Units and Commercial Solution and is responsible for leading the marketing-led strategies for West’s four market units—Biologics, Pharma, Generics and Contract Manufacturing. In her role, she oversees West’s overall sales strategy including the Company’s scientific affairs and technical customer service teams, and also manages West’s commercial strategic partnerships and business development efforts. Cindy most recently served as General Manager, Biologics Market Unit. Prior to joining West, Cindy served as Senior Vice President leading the Marketing and Sales organizations for the Pharma and Biotech business unit at Lonza which provides customized Contract Development and Manufacturing services to Pharmaceutical and Biotech organizations. Cindy holds a Bachelor of Arts in Biological Chemistry from the University of Kansas, where she is a member of the Biological Advisory Board.
What's Cindy Clark's mailing address?
Cindy's mailing address filed with the SEC is , 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341.
Insiders trading at West Pharmaceutical Services
Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci a Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.
What does West Pharmaceutical Services do?
west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
What does West Pharmaceutical Services's logo look like?
Complete history of Ms. Clark stock trades at West Pharmaceutical Services
West Pharmaceutical Services executives and stock owners
West Pharmaceutical Services executives and other stock owners filed with the SEC include:
-
Eric Green,
President, Chief Executive Officer, Director -
Eric M. Green,
Pres, CEO & Director -
Bernard Birkett,
Chief Financial Officer, Senior Vice President -
George Miller,
Senior Vice President, General Counsel, Corporate Secretary -
Bernard J. Birkett,
Sr. VP & CFO -
Silji Abraham,
Senior Vice President and Chief Digital and Transformation Officer -
David Montecalvo,
Senior Vice President, Chief Operating and Supply Chain Officer -
Annette Favorite,
Chief Human Resource Officer, Senior Vice President -
David A. Montecalvo,
Sr. VP and Chief Operations & Supply Chain Officer -
Silji Abraham,
Sr. VP & Chief Technology Officer -
Patrick Zenner,
Independent Chairman of the Board -
Douglas Michels,
Independent Director -
Thomas Hofmann,
Independent Director -
Paula Johnson,
Independent Director -
William Feehery,
Independent Director -
Mark Buthman,
Independent Director -
Myla Lai-Goldman,
Independent Director -
Paolo Pucci,
Independent Director -
Deborah Keller Tanner,
Independent Director -
Chad Winters,
Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller -
Robert Friel,
Independent Director -
Cindy Reiss-Clark,
Senior Vice President of Global Market Units and Commercial Solutions -
Quintin Lai,
Vice President - Corporate Development, Strategy and Investor Relations -
Eric Resnick,
Chief Technology Officer, Vice President -
Richard D. Luzzi,
Sr. VP of HR -
Annette F. Favorite,
Chief HR Officer & Sr. VP -
Michele Polinsky,
VP of Global Communications -
Kimberly Banks MacKay,
Sr. VP, Gen. Counsel & Company Sec. -
Dr. Quintin J. Lai C.F.A., Ph.D.,
VP of Strategy & Investor Relations -
Daniel Malone,
Vice President & Controller -
William J Federici,
VP & CFO -
John H Weiland,
Director -
Karen Flynn,
President, America's Region -
Heino Lennartz,
President Europe -
Anthony Welters,
Director -
Warwick Bedwell,
VP Pharma Pkgs Systems Asia Pa -
John E Paproski,
Vice President-Innovations -
Christopher G Ryan,
President, PPS, Americas -
Rachael M Bushey,
VP, Deputy Gen Coun & Corp Sec -
Jeffrey C Hunt,
VP Pharma Pckg Systems -
John R Gailey,
VP, Gen. Counsel & Sec. -
Richard D Luzzi,
VP, Human Resourses -
L Robert Johnson,
Director -
Michael A Anderson,
Vice President & Treasurer -
Donald E Jr Morel,
Chairman of the Board & CEO -
Robert C Young,
Director -
Donald A Mc Millan,
President Pharma Systems NA -
Steven A Ellers,
Pres., Pharma. Systems Div. -
Geoffrey F Worden,
Director -
John P Neafsey,
Director -
Joseph E Abbott,
Corporate Controller -
Dijk Ronald Van,
President Asia Pacific -
Robert S Hargesheimer,
President-The Tech Group -
Fabio De Sampaio Doria Filho,
Pres., Europe & Asia Pacific -
Matthew T Mullarkey,
Chief Operating Officer -
Robert J Keating,
Pres., Europe & Asia Pacific -
Jenne K Britell,
Director -
Herbert L Hugill,
Pres. of the Americas, Pharma. -
Linda R Altemus,
VP & Chief Compliance Officer -
Molly Joseph,
Director -
Deborah L Keller,
Director -
Stephen H Lockhart,
Director -
Charles Witherspoon,
VP & Treasurer -
Kimberly Banks Mac Kay,
SVP, GC & Corporate Secretary